News
News releases on January 2, 2024, page 3
Every news release public companies put out on January 2, 2024 (UTC): 339 news releases, newest first. Open any release to read it.
NorthWest Copper Announces Closing of Third Tranche of Previously Announced Private Placement and Close of Rights Offering
NorthWest Copper Corp. · Jan 2, 2024
Nextracker Appoints Two New Members to Board of Directors
Nextpower Inc. · Jan 2, 2024
Nextracker Appoints Two New Members to Board of Directors
Flex Ltd. · Jan 2, 2024
Nextracker Announces Completion of Its Separation from Flex
Nextpower Inc. · Jan 2, 2024
Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences, Inc. · Jan 2, 2024
NeuroBo to Participate in Industry and Investor Conferences in January
MetaVia Inc. · Jan 2, 2024
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Neumora Therapeutics, Inc. · Jan 2, 2024
NESR Announces Participation in Upcoming Conferences
National Energy Services Reunited Corp · Jan 2, 2024
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
NeoGenomics, Inc. · Jan 2, 2024
Nature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024
Nature's Sunshine Products, Inc. · Jan 2, 2024
MediaCo Holding Inc. Announces Chris Squire as Senior Vice President of Sales and Marketing for HOT 97 and WBLS
Mediaco Holding Inc. · Jan 2, 2024
MEDIA ALERT: Rambus to Present at 26th Annual Needham Growth Conference
Rambus, Inc. · Jan 2, 2024
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
MannKind Corporation · Jan 2, 2024
Loyalist Exploration Limited Announces Retirement of Chairman
Loyalist Exploration Limited · Jan 2, 2024
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
Liquidia Corporation · Jan 2, 2024
Lands' End Announces Participation in the 26th Annual ICR Conference
Lands' End Inc · Jan 2, 2024
Lands’ End Announces New Term Loan
Lands' End Inc · Jan 2, 2024
Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
Kymera Therapeutics, Inc. · Jan 2, 2024
Kodiak Robotics Selects Ambarella AI Domain Controller SoC For Next-Generation Autonomous Trucks
Ambarella, Inc. · Jan 2, 2024
Knightscope Authorized Partner TS&L Purchases First 13 K1 Blue E-Phones for Georgia State University
Knightscope, Inc. · Jan 2, 2024
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals International, plc · Jan 2, 2024
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
Journey Medical Corporation · Jan 2, 2024
J & J Snack Foods schedules conference call to discuss first quarter financial results
J & J Snack Foods Corp. · Jan 2, 2024
Jasper Therapeutics, Inc. Announces Reverse Stock Split
Jasper Therapeutics, Inc. · Jan 2, 2024
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
iRadimed Corporation · Jan 2, 2024
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2023, includes Reg.-NMS Execution Statis...
Interactive Brokers Group, Inc. · Jan 2, 2024
Interactive Brokers Appoints Rich Repetto to its Board of Directors
Interactive Brokers Group, Inc. · Jan 2, 2024
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
QTREX Quantum Ltd. · Jan 2, 2024
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
Insmed Incorporated · Jan 2, 2024
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
INmune Bio Inc. · Jan 2, 2024
Immunome Appoints Carol A. Schafer to Board of Directors
Immunome, Inc. · Jan 2, 2024
ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 ...
ImmunityBio, Inc. · Jan 2, 2024
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings
IM Cannabis Corp. · Jan 2, 2024
Ichor Announces Participation in 26th Annual Needham Growth Conference
Ichor Holdings · Jan 2, 2024
Hydrofarm Holdings Group to Participate in the 2024 ICR Conference
Hydrofarm Holdings Group, Inc. · Jan 2, 2024
HF Foods To Participate in the 2024 ICR Conference
HF Foods Group Inc. · Jan 2, 2024
Heritage Mining Announces $500,000 Non-Brokered Private Placement of Units and OJEP Approval (Repeat Relase from December 29)
Heritage Mining Ltd. · Jan 2, 2024
Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering
Healthcare Triangle, Inc. · Jan 2, 2024
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
Guardant Health, Inc. · Jan 2, 2024
Good Times Restaurants Inc. Welcomes Keri August as Senior Vice President of Finance and Accounting
Good Times Restaurants Inc. · Jan 2, 2024
GlucoTrack announces early accuracy data for its implantable continuous glucose monitor
GlucoTrack, Inc. · Jan 2, 2024
GameSquare Completes the Sale of Its Non-Core Radio Business Assets
GameSquare Holdings, Inc. · Jan 2, 2024
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Platform Presentation at the 20th Annual WORLDSymposium™ 2024
Gain Therapeutics, Inc. · Jan 2, 2024
Funded status of largest U.S. corporate pension plans ends 2023 at 100%
Willis Towers Watson Public Limited Company · Jan 2, 2024
Freshpet, Inc. to Participate in the 2024 ICR Conference
Freshpet, Inc. · Jan 2, 2024
Franklin Electric Acquires U.S. Groundwater Distribution Company
Franklin Electric Co., Inc. · Jan 2, 2024
FOX News Channel to Host Primetime Town Hall With Former President Donald Trump on January 10
Fox Corporation · Jan 2, 2024
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Fortrea Holdings Inc. · Jan 2, 2024
Fortinet to Announce Fourth Quarter and Full Year 2023 Financial Results
Fortinet, Inc. · Jan 2, 2024
FLEX announces completion of the spin-off of its remaining interest in nextracker
Flex Ltd. · Jan 2, 2024
Faraday Future Delivers an FF 91 2.0 to its Newest User, Jim Gao, Vice President of FF’s Intelligent Internet Application Service Platfor...
Faraday Future Intelligent Electric Inc. · Jan 2, 2024
Exelixis to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024
Exelixis, Inc. · Jan 2, 2024
Evolv Technology to Release Fourth Quarter Financial Results on February 29, 2024
Evolv Technologies Holdings, Inc. · Jan 2, 2024
EverQuote to Participate at the 26th Annual Needham Growth Conference
EverQuote, Inc. · Jan 2, 2024
Euro Manganese Announces Resignation of Board Member
Euro Manganese, Inc. · Jan 2, 2024
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
Establishment Labs Holdings Inc. · Jan 2, 2024
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
PMGC Holdings Inc. · Jan 2, 2024
Element79 Gold Announces Management Cease Trade Order
Element79 Gold Corp. · Jan 2, 2024
Eldorado Gold Announces Appointment of Paul Ferneyhough as Executive Vice President and Chief Financial Officer
Eldorado Gold Corporation · Jan 2, 2024
EchoStar Corporation Completes Merger with DISH Network Corporation
EchoStar Corporation · Jan 2, 2024
Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8: 00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials
Dyne Therapeutics, Inc. · Jan 2, 2024
Donegal Insurance Group Names Two to Posts of Chief Operating Officer, SVP of Field Operations & National Accounts
Donegal Group, Inc. · Jan 2, 2024
DISH Network Convertible Notes Become Convertible Into Shares of EchoStar Corporation
EchoStar Corporation · Jan 2, 2024
Dave George and Jon Sagal Appointed to Bloomin’ Brands Board of Directors
Bloomin' Brands, Inc. · Jan 2, 2024
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
Xencor, Inc. · Jan 2, 2024
Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cytokinetics, Incorporated · Jan 2, 2024
Community Trust Bancorp Announces Nicholas Antimisiaris Promoted to Vice President, Corporate Information Security, Resilience and Data O...
Community Trust Bancorp, Inc. · Jan 2, 2024
Columbus McKinnon Announces Kristine Moser as Vice President, Investor Relations and Treasurer
Columbus McKinnon Corporation · Jan 2, 2024
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
CollPlant Biotechnologies Ltd. · Jan 2, 2024
Coherus Announces U.S. Launch of LOQTORZI™
Coherus Oncology, Inc. · Jan 2, 2024
Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Cogent Biosciences, Inc. · Jan 2, 2024
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. · Jan 2, 2024
Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters
Citius Pharmaceuticals, Inc. · Jan 2, 2024
Cipher Mining Announces December 2023 Operational Update
Cipher Digital Inc. · Jan 2, 2024
Check Point Software to Announce Fourth Quarter and Full Year 2023 Financial Results on February 6, 2024
Check Point Software Technologies Ltd. · Jan 2, 2024
Cardlytics Appoints Two New Members to its Board of Directors
Cardlytics, Inc. Common Stock · Jan 2, 2024
Canadian North Resources Reports Results of Borehole Geophysical Surveys Indicating Extensions of Deep Nickel-Copper-PGM Sulfide Zones at...
Canadian North Resources, Inc. · Jan 2, 2024
Caesars Entertainment, Inc. to Report 2023 Fourth Quarter and Full Year Results on February 20, 2024
Caesars Entertainment, Inc. · Jan 2, 2024
Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cabaletta Bio, Inc. · Jan 2, 2024
BTC Digital Ltd. Announces Purchase of 2,000 Units of T21 Miners
BTC Digital Ltd. · Jan 2, 2024
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
Bluejay Diagnostics, Inc. · Jan 2, 2024
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Beam Therapeutics Inc. · Jan 2, 2024
BayFirst Financial Corp. Appoints Thomas G. Zernick as CEO and Names Robin Oliver as President, Effective January 1, 2024
BayFirst Financial Corp. · Jan 2, 2024
Athena Gold Welcomes Eric Sprott as Shareholder and Closes Acquisition of 10 Million Shares in Nubian Resources
Athena Gold Corporation · Jan 2, 2024
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
AtaiBeckley Inc. · Jan 2, 2024
AST SpaceMobile Provides Interim Update on Fundraising
AST SpaceMobile, Inc. · Jan 2, 2024
Asia Pacific Wire & Cable Corporation Limited Reports Third Quarter 2023 Financial Results
Asia Pacific Wire & Cable Corporation Limited · Jan 2, 2024
Ashley Gold Closes Burnhut Property Acquisition and Closes Second Tranche of Financing
Ashley Gold Corp. · Jan 2, 2024
Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Apogee Therapeutics, Inc. · Jan 2, 2024
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Apellis Pharmaceuticals, Inc. · Jan 2, 2024
Anavex Life Sciences Provides an Update on Rett Syndrome Program
Anavex Life Sciences Corp. · Jan 2, 2024
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Amphastar Pharmaceuticals, Inc. · Jan 2, 2024
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, Precision...
Cardio Diagnostics Holdings Inc. · Jan 2, 2024
Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024
Altimmune, Inc. · Jan 2, 2024
Alnylam to Webcast Presentation at 42nd Annual J.P. Morgan Healthcare Conference
Alnylam Pharmaceuticals, Inc. · Jan 2, 2024
Align Technology to Announce Fourth Quarter and 2023 Results on January 31, 2024
Align Technology, Inc. · Jan 2, 2024
Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement
Ainos, Inc. · Jan 2, 2024
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
Agios Pharmaceuticals, Inc. · Jan 2, 2024
Aehr Test Systems to Announce Second Quarter Fiscal 2024 Financial Results on January 9, 2024
Aehr Test Systems · Jan 2, 2024
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
Aditxt, Inc. · Jan 2, 2024